Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of clinical …, 2015 - ascopubs.org
Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …
被引用次数：206 相关文章

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk

TA King, M Pilewskie, S Muhsen… - Journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …
[HTML] nih.gov

[HTML][HTML] Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic
Features and Breast Cancer Risk - PMC Back to Top Skip to main content NIH NLM Logo …

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of Clinical …, 2015 - europepmc.org
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating
Clinicopathologic Features and Breast Cancer Risk. - Abstract - Europe PMC Sign in …
[PDF] academia.edu

[PDF][PDF] Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk

TA King, M Pilewskie, S Muhsen, S Patil, SK Mautner… - J Clin Oncol, 2015 - academia.edu
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic
Features and Breast Cancer Risk Page 1 Lobular Carcinoma in Situ: A 29-Year Longitudinal …

Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk

TA King, M Pilewskie, S Muhsen, S Patil… - JOURNAL OF …, 2015 - air.unimi.it
Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …

[引用][C] Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk

TA King, M Pilewskie, S Muhsen… - Journal of …, 2015 - baptisthealth.elsevierpure.com
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic
Features and Breast Cancer Risk — Baptist Health South Florida's Research Portal Skip to …

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of Clinical …, 2015 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> The increased breast cancer risk
conferred by a diagnosis of lobular carcinoma in situ (LCIS) is poorly understood. Here, we …
[HTML] nih.gov

[HTML][HTML] Lobular carcinoma in situ: A 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here we review our 29-year longitudinal experience with …

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.

TA King, M Pilewskie, S Muhsen, S Patil… - Journal of Clinical …, 2015 - europepmc.org
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic
Features and Breast Cancer Risk. - Abstract - Europe PMC Sign in | Create an account …